Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Cardiovascular effects of isoproterenol and possible antagonistic actions of propranolol and perhexiline.

Matsukawa H, Okabe E, Sakamoto H, Cho YW, Ito H.

Jpn Circ J. 1978 Apr;42(4):425-32.

PMID:
29976
2.

Effects of perhexiline on hemodynamics in anesthetized open-chest dogs.

Ono H, O'Hara N, Hashimoto K.

Jpn Heart J. 1981 Nov;22(6):951-8.

PMID:
7339008
3.
4.

Adrenoceptor blockade of the circulatory responses to intravenous isoproterenol.

Richards DA, Prichard BN, Dobbs RJ.

Clin Pharmacol Ther. 1978 Sep;24(3):264-73. No abstract available.

PMID:
28869
5.
6.

Cardiovascular and beta-adrenergic blocking effects of timolol.

Mouillé P, Schmitt H, Cheymol G, Gauter E.

Eur J Pharmacol. 1976 Feb;35(2):235-43.

PMID:
2481
7.

Cardiac actions of oxprenolol as studied in dog heart-lung preparations.

Takeda K, Iizuka H, Imai S.

Arzneimittelforschung. 1973 Oct;23(10):1446-50. No abstract available.

PMID:
4149692
8.

[Bepridil, a functional antagonist of beta1-adrenergic stimulation. Dissociated effects on cardiostimulation and lipolysis. (author's transl)].

Constantin M, Beaughard M, Piris P, Labrid C.

J Pharmacol. 1981 Jul-Sep;12(3):239-54. French.

PMID:
6116833
9.
10.
11.

Effects of perhexiline on myocardial phosphorylase activity, myocardial catecholamine content and heart rate.

Okabe E, Higashi H, Fujisawa T, Cho YW, Ito H.

Jpn Circ J. 1981 Jun;45(6):667-71.

PMID:
6113292
12.

[Proceedings: Review of the cardiovascular pharmacology of perhexiline].

Hudak WJ, Lewis RE, Lucas RW, Kuhn WL.

Postgrad Med J. 1973 Apr;49:Suppl 3:16-25. Review. No abstract available.

PMID:
4202743
13.

The comparative hemodynamic effects of propranolol in chronically instrumented puppies and adult dogs.

Driscoll DJ, Fukushige J, Lewis RM, Hartley CJ, Entman MJ.

Biol Neonate. 1982;41(1-2):8-15.

PMID:
7066441
14.

Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.

Baum T, Rowles G, Shropshire AT, Gluckman MI.

J Pharmacol Exp Ther. 1971 Feb;176(2):339-49. No abstract available.

PMID:
4398186
15.

Soft drug derivatives related to perhexiline. Part II: In vivo studies.

Decker N, Grima M, Velly J, Marciniak G, Leclerc G, Schwartz J.

Arzneimittelforschung. 1988 Aug;38(8):1110-4.

PMID:
3196404
16.

Effects of endotoxin on myocardial hemodynamics, performance, and metabolism during beta adrenergic blockade.

Hinshaw LB, Greenfeild LJ, Archer LT, Guenter CA.

Proc Soc Exp Biol Med. 1971 Sep;137(4):1217-24. No abstract available.

PMID:
4400322
17.

Cardiovascular effects of 5-hydroxypropranolol (ORF 12592) in dogs.

Ram N, Bauer EW, Hesse UC, Heilman RD.

Arch Int Pharmacodyn Ther. 1977 Jul;228(1):118-25.

PMID:
921395
18.

Pharmacology of nadolol (SQ 11725), a beta-adrenergic antagonist lacking direct myocardial depression.

Lee RJ, Evans DB, Baky SH, Laffan RJ.

Eur J Pharmacol. 1975 Sep-Oct;33(2):371-82.

PMID:
241655
19.

Pharmacodynamic studies of beta adrenergic antagonism induced in man by propranolol and practolol.

Bodem G, Brammell HL, Weil JV, Chidsey CA.

J Clin Invest. 1973 Apr;52(4):747-54.

20.

Some cardiovascular effects of timolol a new beta-adrenergic blocking agent.

Scriabine A, Torchiana ML, Stavorski JM, Ludden CT, Minsker DH, Stone CA.

Arch Int Pharmacodyn Ther. 1973 Sep;205(1):76-93. No abstract available.

PMID:
4148410

Supplemental Content

Support Center